SCHEMBL1991648

SCHEMBL1991648

CCOC(=O)Cc1cn(CC2CCN(C(=O)OC(C)(C)C)CC2)c2ccccc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.62
KDM4E B2RXH2 2/20 0.49
PKM P14618 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.43
CHRM2 P08172 1/20 0.43
CHRM4 P08173 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
USP2 O75604 1/20 0.43
HSD17B10 Q99714 1/20 0.43
GPR119 Q8TDV5 3/20 0.41
PRKCG P05129 1/20 0.41
PRKCB P05771 1/20 0.41
PRKCA P17252 1/20 0.41
PRKCH P24723 1/20 0.41
PRKCE Q02156 1/20 0.41
PRKCD Q05655 1/20 0.41
HTR6 P50406 1/20 0.41
CNR1 P21554 1/20 0.41
CREBBP Q92793 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1989207 0.85 L3MBTL1 (0.50) L3MBTL1KDM4ESMN1; SMN2HTR6CNR1
SCHEMBL1990227 0.81 L3MBTL1 (0.50) L3MBTL1KDM4EPKMCNR1CREBBP
SCHEMBL1993899 0.80 L3MBTL1 (0.48) L3MBTL1KDM4EPKMSMN1; SMN2CHRM2
SCHEMBL16880224 0.78 HTR6 (0.46) KDM4EPKMCHRM2CHRM4CHRM1
SCHEMBL31668261 0.77 HTR6 (0.47) KDM4EPKMCHRM2CHRM4CHRM1
SCHEMBL5740608 0.77 L3MBTL1 (1.00) L3MBTL1KDM4EPKMSMN1; SMN2HTR6
SCHEMBL4077650 0.77 HTR6 (0.51) KDM4EPKMCHRM2CHRM4CHRM1
SCHEMBL1994772 0.77 KDM4E (0.44) L3MBTL1KDM4EPKMCHRM2CHRM4
SCHEMBL7842723 0.77 HTR6 (0.49) L3MBTL1HTR6CNR1
SCHEMBL1992845 0.77 CHRM2 (0.48) KDM4EPKMCHRM2CHRM4CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO L3MBTL1 3898/4885KDM4E 3351/4885PKM 833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.